Explain what these adjustments represent and whether you believe they were appropriate adjustments to make for a key performance metric like non-GAAP operating income.
Case : Valeant Pharmaceuticals 2015 Submit the following individually: • What FY 2015 metrics did Valeant guide for during H1 15. You can also look for guidance figures in other transcripts and investor presentations during H1 15. • What comparable GASP results did the Company end up achieving for FY 15? • Identify the three […]